Adding a new study drug for generalized anxiety disorder
Part of Mental health clinical trials.
This trial tests a new medication, JNJ-99245354 (also called ITI-1284), added to your current anxiety treatment to see if it helps reduce anxiety symptoms. You may be eligible if you've already tried at least one FDA-approved treatment for generalized anxiety disorder without enough improvement.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be medically stable, as shown by a physical exam, medical history, vital signs, ECG, and lab tests.
- Have had an inadequate response to at least one approved GAD treatment taken at a proper dose and for a proper length of time.
- Be an outpatient and stay an outpatient during the study.
- Have a body mass index (BMI) between 19 and 40.
- Not have a lifetime history of schizophrenia, bipolar disorder, or other psychotic disorders.
- Not have other major psychiatric conditions within the last 6 months (except mild depression or social anxiety).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental medication (ITI-1284) added to your current anxiety treatment to see if it improves symptoms. It's for adults with generalized anxiety disorder (GAD) who haven't gotten enough relief from their current medicine.
This study tests an investigational oral medication (ITI-1284) for people with moderate to severe generalized anxiety disorder (GAD) who haven't found enough relief from at least two standard medications. The goal is to see if this new drug helps reduce anxiety symptoms.
This trial tests an investigational medication to see if it can reduce anxiety symptoms in adults with generalized anxiety disorder. Participants will receive the study drug and be monitored for safety and effectiveness.
This study tests a new medicine (SEP-363856) for adults with generalized anxiety disorder to see if it reduces anxiety symptoms and is safe. It may help if other treatments haven't worked well.
This study is testing a new medication for generalized anxiety disorder. It will check if the drug is safe and well-tolerated when taken alone or alongside your current anxiety treatment.
This trial tests a new medicine called SYT-510 for adults with generalized anxiety disorder who are not currently taking medication. It aims to see if the drug reduces anxiety and is safe.
Hear when a new Generalized Anxiety Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.